Skip to main content

Verified Treatment Center

Spero Health Indiana

Lexington, KY · 40503

SAMHSA Verified Outpatient MAT
Specializes in Dual Diagnosis Trauma-Informed Pregnancy-Postpartum

Key Takeaways for Spero Health Indiana

  • Outpatient · MAT offered
  • Accepts Medicaid, Medicare, Private insurance, TRICARE/VA
  • SAMHSA-listed facility
  • Direct line available · Helpline free & confidential 24/7

About Spero Health Indiana

Spero Health Indiana is a SAMHSA-registered addiction-treatment facility located at Lexington, KY. The facility's programming is outpatient (Outpatient, MAT), not residential. Patient-level evaluation of this facility should distinguish three considerations: state licensure status, voluntary accreditation (CARF or Joint Commission), and clinical-framework alignment with current ASAM Criteria — each of which is independently verifiable.

Care levels at Spero Health Indiana

Spero Health Indiana is an outpatient-focused program (Outpatient, MAT) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. Operational prerequisite for admission: documented clinical assessment establishing medical necessity for the specific level of care Spero Health Indiana provides. The ASAM Criteria 4e framework is the benchmark standard for this assessment and is referenced in most major payer medical-necessity documents.

Insurance and payment

Payment and insurance posture: Spero Health Indiana accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The facility also accepts TRICARE or military benefits. Pre-admission Verification of Benefits (VOB) documentation should include: specific plan product and network status, deductible status at time of admission, coinsurance rate applicable, prior authorization status and turnaround, and out-of-pocket accumulation. Under MHPAEA 2024 disclosure rules, plan-specific medical-necessity criteria must be available on request.

Specialty programming

The facility's documented specialty programming includes: Adult women, Pregnant/postpartum women, Adult men. Specialty-program verification requires review of: (a) dedicated specialty-track programming hours per week; (b) specialty-credentialed clinical staffing (e.g., LCSW with trauma specialization, perinatal-nurse certification, adolescent-development training); (c) specialty-specific clinical assessment protocols; (d) specialty-specific outcome measurement. Marketing designation alone is insufficient for clinical confidence.

Before you call

Pre-admission documentation for Spero Health Indiana should include ASAM-framework level-of-care justification, plan-specific Verification of Benefits with network-contract confirmation, written MAT policy for opioid use disorder patients where applicable, and licensure/accreditation verification. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.

Listing sourced from the SAMHSA Behavioral Health Treatment Services Locator. Data last synced April 2026. Verify current programs directly with the facility.

Spero Health Indiana at a Glance

Levels of care

Outpatient · MAT

Service settings

Outpatient, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment

Therapy approaches

Anger management, Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Matrix Model

Age groups

Young Adults, Adults

Special populations

Adult women, Pregnant/postpartum women, Adult men, Seniors or older adults, Criminal justice (other than DUI/DWI)/Forensic clients, Clients with co-occurring mental and substance use disorders

Medications

Acamprosate (Campral®), Buprenorphine sub-dermal implant, Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral)

Insurance & Payment Accepted

Confirm in-network status before admission — verification is free.

Private insurance

Coverage details →

TRICARE / VA

Coverage details →

Contact & Location

Address

177 Burt Road, Lexington, KY 40503

Facility direct line

(317) 623-3007

Website

sperohealth.com